ChatGPT

Perplexity

Gemini

Claude

Grok

The PleurX app is for patients and caregivers to manage their at-home drainage. The PleurX app is used on a smartphone or tablet. There is no connection between patients and clinicians directly throug

The BD Events mobile meeting app houses events and meetings for BD Associates. This app will allow attendees to stay up-to-date with the latest program information and receive real-time notification f

When selecting a vascular access device, are you considering both the infusates and the potential infusion complications? Thrombosis, thrombophlebitis, phlebitis, necrosis following extravasation of a

The BD MDS Assessment Mobile app is an easy-to-use data collection tool for BD clinical and sales teams to collect vascular access related data at the hospital’s facility. This data is to be used for 

Integrity is paramount at BD, emphasizing honesty, ethics, and transparency in all business practices. The company maintains the highest standards of ethical conduct.

We Do What Is Right

BD is dedicated to continuous innovation, pushing technological boundaries to deliver cutting-edge healthcare solutions, demonstrated by substantial investment in research and development exceeding $1.2 billion in 2024.

We Thrive on Innovation

Quality is non-negotiable at BD. Every product and service must meet rigorous standards to ensure patient safety and clinical effectiveness.

We Demand Quality

Every BD associate takes ownership of their work and its impact on patients, customers, and colleagues, fostering a culture of responsibility.

We Are All Accountable

BD promotes continuous learning and development, encouraging associates to grow professionally and improve processes constantly.

We Learn and Improve Every Day

Becton, Dickinson and Company (BD) is a global medical technology company that develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products. Operating through three divisions—BD Medical, BD Life Sciences, and BD Interventional—BD serves healthcare institutions, physicians, life science researchers, clinical laboratories, and the pharmaceutical industry.

Tom Polen

Chairman, CEO and President

Christopher DelOrefice

Executive Vice President and CFO

Mike Garrison

Executive Vice President and Medical Segment President

Rick Byrd

Executive Vice President and Interventional Segment President

Shana Neal

Executive Vice President and Chief People Officer

Denise Russell Fleming

Chief Information Officer and EVP of Technology and Global Services

Pamela Spikner

Senior Vice President, Chief Accounting Officer and Controller

Becton, Dickinson and Company is an American medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs nearly 70,000 people in more than 50 countries throughout the world. In the fiscal year ending September 30, 2019, more than 40% of BD sales were generated from non-U.S. markets. The company's customers include health care institutions, science researchers, clinical laboratories, the pharmaceutical industry, and the general public. BD was one of the first companies to sell U.S.-made glass syringes. It was also a pioneer in the production of hypodermic needles. Today, BD is divided into three segments: BD Medical, BD Life Sciences and BD Interventional. BD is ranked #195 in the 2019 Fortune 500 list.

https://en.wikipedia.org/wiki/Becton_Dickinson

Intelligent pharmacy automation systems and medication dispensing technologies that use artificial intelligence and analytics to improve efficiency and safety of patient care, including the Pyxis MedStation system.

Medication Management Solutions

Comprehensive portfolio of IV catheters, PICC lines, flush solutions, and advanced vascular access technologies that enable safe and effective delivery of medications and fluids to patients.

Vascular Access and Management

Industry-leading syringes, hypodermic needles, and injection devices used worldwide for medication administration, vaccinations, and medical procedures, including safety-engineered products.

Syringes and Needles

The Vacutainer system and related blood collection products that set the standard for safe, efficient blood specimen collection in laboratories and clinical settings worldwide.

Blood Collection Systems

Leader in microbiology and infectious disease diagnostics, including molecular diagnostics, microbiology automation systems, and point-of-care testing solutions for hospitals and laboratories.

Diagnostic Solutions

Critical care monitoring systems including hemodynamic monitoring, capnography, and related technologies acquired from Edwards Lifesciences to enhance patient safety in hospital settings.

Advanced Patient Monitoring

Peripheral vascular disease treatments, interventional cardiology products, and specialty access devices for minimally invasive procedures.

Interventional Solutions

BD announced Q4 fiscal 2025 revenue of $5.9 billion with 8.3% reported growth and 3.9% organic growth, bringing full-year revenue to $21.8 billion, an increase of 8.2%. The Board of Directors declared a quarterly dividend of $1.05 per common share, a 1.0% increase.

BD Reports Fourth Quarter and Full Year Fiscal 2025 Financial Results

BD announced a $17.5 billion Reverse Morris Trust agreement to combine BD's Biosciences and Diagnostic Solutions business with Waters Corporation, creating an innovative life science and diagnostic leader. The transaction is expected to close around the end of Q1 calendar year 2026.

BD and Waters Corporation Announce Agreement to Combine BD's Biosciences and Diagnostic Solutions Business

BD announced additional investments in its U.S. manufacturing network with more than $30 million planned for 2025 to expand capacity for IV lines at its Utah plant, building on $10 million invested in 2024 for new needle and syringe production lines in Connecticut and Nebraska.

BD Boosts U.S. Manufacturing of Critical Medical Devices

BD completed the $4.2 billion acquisition of the Critical Care business from Edwards Lifesciences, forming the Advanced Patient Monitoring (APM) business unit within BD's Interventional segment. This acquisition strengthens BD's position in hemodynamic monitoring and critical care.

BD Completes Acquisition of Edwards Lifesciences Critical Care Business

BD was named to TIME's 2024 list of the World's Best Companies, which identifies top-performing organizations globally based on employee satisfaction, revenue growth, and sustainability. This recognition highlights BD's commitment to innovation and creating value for stakeholders.

BD Named by TIME as One of the World's Best Companies

BD was recognized as one of the 100 Best Corporate Citizens of 2024 by 3BL, ranking second in the healthcare equipment and services industry for the second consecutive year. The recognition acknowledges BD's excellence in environmental, social, and governance (ESG) performance.

BD Named Among the 100 Best Corporate Citizens of 2024

BD received the Business Group on Health 'Best Employers: Excellence in Health & Well-being Award' for its commitment to advancing employee well-being through comprehensive benefits and innovative initiatives. BD also received honors for 'Excellence in Global Health & Well-being.'

BD Named Best Employer for Excellence in Employee Well-Being

Has anyone worked for Becton Dickinson?

Becton Dickinson &amp; Co. APM role (Formally Edwards Lifesciences CC)

Received a tender offer from Becton, Dickinson and Company (BDX). Can someone help translate this?

Did I botch the interview with BD?

BDX stock Becton, Dickinson showing wrong data?

Becton Dickinson &amp; Co

Becton, Dickinson and Company Announces Pricing of the Tender Offers and Amounts Accepted for Purchase

Becton, Dickinson and Company Announces Early Tender Results and Upsizing of Offer SubCap and Aggregate Offer Cap

📢 is [hiring] a Sales Compensation Associate Analyst - Becton Dickinson Medical Devices - United States!

MedicalDevices

Quantisnow

jobboardsearch

WFHJobs

bonds

TradingView

edgar_news

BECTON DICKINSON & CO

Surgical & Medical Instruments & Apparatus

Maxwell W. Becton and Fairleigh S. Dickinson established Becton, Dickinson and Company in New York City to sell and manufacture medical thermometers and syringes.

Company Founded

BD secured its first patent for an all-glass syringe, marking the beginning of the company's innovation legacy.

First Patent Secured

The partnership was officially incorporated as Becton, Dickinson & Company, and a factory was built in East Rutherford, New Jersey, establishing BD's manufacturing presence.

Official Incorporation and Factory Opening

BD introduced the ACE bandage ('All Cotton Elastic'), which became one of the most recognized medical products in healthcare history.

ACE Bandage Introduction

BD launched the Vacutainer blood collection tube, revolutionizing blood collection and marking BD's entry into diagnostic medicine.

Vacutainer Launch

BD became a public company, with its stock trading on the New York Stock Exchange the following year.

Public Company

BD launched the first fluorescence-activated cell sorter, advancing life sciences research capabilities.

Cell Sorter Innovation

BD completed acquisitions of PharMingen Inc. ($217.4M) and Difco Laboratories Incorporated, expanding its reagents and microbiology capabilities.

Major Acquisitions

BD acquired CareFusion, a leading medical technology company, significantly expanding its medication management and infection prevention portfolio.

CareFusion Acquisition

BD completed the acquisition of C.R. Bard, creating one of the largest medical device companies globally and establishing the Interventional segment.

C.R. Bard Acquisition

BD completed the acquisition of Edwards Lifesciences' critical care unit for $4.2 billion, forming the Advanced Patient Monitoring business unit.

Edwards Lifesciences Critical Care Acquisition

BD announced a $17.5 billion Reverse Morris Trust deal to combine BD's Biosciences and Diagnostic Solutions business with Waters Corporation, expected to close in Q1 2026.

Waters Corporation Combination Announced

BD announced over $30 million in investments for 2025 to expand manufacturing capacity for IV lines in Utah, building on $10 million invested in 2024 for needle and syringe production.

U.S. Manufacturing Expansion

American multinational medical technology company

Explore the latest styles in fashion, home and beauty with the H&M app. Discover inspiring collections and intuitive features that simplify the shopping experience — from instant search to real-time o

Your top app for online fashion shopping in Saudi Arabia, United Arab Emirates, Kuwait, Egypt, and Qatar.  Download the H&M app and shop all fashion clothing and accessories such as:

- Women's clothe

Erling Persson (1947 Sweden, retail entrepreneur)

Germany fines H&M 35 million euros for data protection breaches

H & M Hennes & Mauritz AB, commonly known by its brand name H&M, is a Swedish multinational clothing company headquartered in Stockholm. Built on a fast fashion business model, the retailer sells apparel, accessories, and homeware. The company operates thousands of stores across 75 geographical markets and employs over 171,000 people worldwide. H&M is the second-largest international clothing retailer after Inditex. H&M was founded by Erling Persson in 1947 under the name Hennes. The CEO of H&M from 2020 to 2024 was Helena Helmersson. The current CEO, as of January 2024, is Daniel Ervér.

Swedish multinational clothing-retail company

H&M generated $22B revenue 2024 as 2nd-largest fashion retailer (Swedish privately-held Persson family, 4,000+ stores 75 countries down from 5,000 peak, fast-fashion $10-40 T-shirts/dresses/basics, Conscious Collection sustainability 50% recycled). Founded 1947 Sweden as Hennes ('Hers') by Erling Persson (women's clothing, 1968 acquired Mauritz Widforss menswear rebranded H&M). 1970s-2000s global (U.S. 2000 NYC, 3,000+ stores, designer collaborations Karl Lagerfeld 2004 $100M sellout). However, 2015-2024 struggles: inventory crisis $4B unsold 2018 (slow fashion cycles versus Zara 2-week, store closures 500+, online 30% transition late), sustainability backlash greenwashing allegations Conscious Collection 5% actually recycled, Shein $30B ultra-fast $5-15 Gen Z. Competing Zara $30B #1 Inditex, Uniqlo $20B basics, Shein $30B online-only $5. Technology: mobile app, membership loyalty, digital receipts, inventory AI predictive limited. Employees 100,000+ (from 120K peak, store closures layoffs).

H&M's Sustainability Push and Inventory Crisis Navigate Fast-Fashion Backlash as Zara Competition and Shein $30B Ultra-Fast Threaten Market Share

H&M reaches $22B revenue as 2nd-largest global fashion retailer with 4,000+ stores, fast-fashion $10-40 model, Swedish origins, struggling Zara competition

H&M HENNES & MAURITZ AB

Women's clothing 'Hers'. Affordable fashion U.S.-inspired. 15 stores Sweden expansion.

Hennes & Mauritz. Added men's hunting/outdoor apparel. Stockholm stock. Sweden national chain.

Fifth Avenue flagship. 3,000+ stores. Fast-fashion model 2-4 week cycles. Zara competition began.

Stella McCartney, Balmain, Versace collabs. Prestige affordable $50-100. Marketing hype lines.

Recycled materials 50% claim. Greenwashing allegations 5% actually recycled. Garment collecting stores.

Slow fashion cycles vs Zara 2-week. Online 30% late transition. Shein $30B $5-15 Gen Z ultra-fast threat.

CEO Helena Helmersson sustainability. Persson family billionaires privately-held. 100K employees (from 120K). Online 30%.

Becton Dickinson vs H&M (Hennes & Mauritz)

Becton Dickinson

About

H&M (Hennes & Mauritz)

About

AI Visibility Head-to-Head

Also Compare

Track AI Visibility in Real Time